(Bloomberg) -- Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing ...

Last month, Sanofi reached an agreement in principle to settle 4,000 lawsuits linking Zantac to cancer. Sanofi did not ...

GSK is not the only company that has settled Zantac cancer lawsuits. Pfizer and Sanofi both agreed to settle a combined 14,000 additional cases earlier this year.

Sanofi, Pfizer, and Boehringer Ingelheim – will not have to face around thousands of lawsuits brought in federal court, although they still face many thousands more filed at the state level.

MediciNova (MNOV) was notified by Sanofi (SNY) that the Sanofi/Novartis (NVS) litigation was settled. Accordingly, MediciNova is entitled to ...

The 51-year-old from Northamptonshire, in central England, was diagnosed with incurable cancer in 2015. After he stopped ...

In a statement Sanofi said it had agreed to pay Genzyme investors $315 million to settle the lawsuit. As part of Sanofi’s $20 billion takeover of Genzyme, the French drugmaker promised ...

Johnson & Johnson is reportedly nearing enough support to finalize a $6.5 billion settlement for lawsuits related to cancer cases linked to its baby powder and other talc products. A pregnant ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

Plaintiffs’ attorneys have brought numerous class action lawsuits alleging glyphosate caused cancer, specifically ... Bayer decided to settle the litigation to manage its costs.